Cargando…
Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
The undetectable onset of glioma and the difficulty of surgery lead to a poor prognosis. Appropriate biomarkers for diagnosis and treatment need to be identified. Interleukin-1 receptor-associated kinase 4 (IRAK4) is involved in the initiation and progression of cancer. However, up until now, no rep...
Autores principales: | Wang, Jialin, Liu, Binfeng, Yao, Jiawei, Liu, Zhendong, Wang, Hongbo, Zhang, Bo, Lian, Xiaoyu, Ren, Zhishuai, Liu, Liyun, Gao, Yanzheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882878/ https://www.ncbi.nlm.nih.gov/pubmed/33664818 http://dx.doi.org/10.3892/ol.2021.12516 |
Ejemplares similares
-
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021) -
Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021) -
Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021) -
ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021) -
Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
por: Liu, Binfeng, et al.
Publicado: (2021)